Court Restrains Medreich from Using Jubilant's Losartan, Amlodipine, Citalopram Dossiers Farhat Nasim7 March 2025 6:44 PM ISTNoida: In relief to Jubilant Generics Ltd, the Commercial Court No. II, Gautam Buddh Nagar, has granted a temporary injunction against Medreich...
Misuse of Confidential Drug Dossiers for Losartan, Citalopram, Amlodipine: Noida Court Upholds Jubilant Generics' Injunction Against Rivals Farhat Nasim14 Nov 2024 4:38 PM ISTNoida: A commercial court in Noida has upheld the injunction in favor of Jubilant Generics, preventing companies from manufacturing and supplying...
USFDA concludes audit at Jubilant Generics Roorkee site Ruchika Sharma3 Feb 2024 1:30 PM ISTNoida: Jubilant Pharmova Limited announced that the United States Food and Drug Administration (USFDA) has concluded audit of the solid dosage...
Jubilant Generics Roorkee facility determined as official action indicated Ruchika Sharma31 Oct 2022 12:46 PM ISTNoida: Jubilant Pharmova Limited's wholly owned subsidiary Jubilant Pharma Limited, today announced that its subsidiary Jubilant Generics Limited...
Jubilant Pharmova Roorkee facility gets 6 USFDA observations Rahul Verma5 Aug 2022 4:12 PM ISTJubilant Pharmova Limited has announced that the United States Food and Drug Administration (USFDA) has recently concluded audit of the Solid Dosage...
USFDA issues 6 observations for Jubilant Pharmova Roorkee facility Ruchika Sharma3 Aug 2022 12:15 PM ISTNoida: Jubilant Pharmova Limited has announced that the United States Food and Drug Administration (USFDA) has recently concluded audit of the Solid...
USFDA removes Jubilant Generics' Olanzapine, Spironolactone and Valsartan from list of excepted products from import Ruchika Sharma14 July 2022 4:09 PM ISTPost this currently only Risperidone orally disintegrating tablets are allowed for import into the US from the Roorkee facility.
Saptagir Labs, Jubilant Generics join hands to manufacture Remdesivir MD Bureau15 Sept 2020 1:00 PM ISTRemdesivir is an experimental antiviral drug developed by Gilead Sciences, Inc. as a course of treatment for COVID-19.
Saptagir Labs, Jubilant Generics join hands to manufacture Remdesivir MD Bureau14 Sept 2020 1:22 PM ISTRemdesivir is an experimental antiviral drug developed by Gilead Sciences, Inc. as a course of treatment for COVID-19.
Jubilant Life Sciences launches remdesivir under brand name JUBI-R in India Ruchika Sharma4 Aug 2020 1:00 PM ISTNoida: Jubilant Life Sciences Limited, an integrated global pharmaceutical and life sciences company, has announced that its...
Jubilant Life Sciences gets DCGI nod to JUBI-R for treating COVID-19 patients Ruchika Sharma21 July 2020 5:16 PM ISTNoida: Jubilant Life Sciences Limited, an integrated global pharmaceutical and life sciences company, has announced that its subsidiary, Jubilant...
Jubilant Life Sciences releases Q4 and FY20 Results Ruchika Sharma30 May 2020 1:25 PM ISTNoida: The Board of Jubilant Life Sciences Limited, an integrated global pharmaceutical, and life sciences company met to approve financial results...
